In vitro and in vivo wound healing-promoting activities of β-lapachone

American Journal of Physiology - Cell Physiology

Volumn 295, Issue 4, 2008, Pages

  Kung, Hsiu Ni ^a   Yang, Mei Jun ^a   Chang, Chi Fen ^a   Chau, Yat Pang ^b   Lu, Kuo Shyan ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cell proliferation; Mitogen activated protein kinase signaling pathways

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BETA LAPACHONE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 14; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; LOW DRUG DOSE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE REGENERATION; WOUND; WOUND HEALING;

ANIMALS; ANTI-INFECTIVE AGENTS; CELL CYCLE; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NAPHTHOQUINONES; SKIN; WOUND HEALING;

ANIMALIA; MUS; TABEBUIA AVELLANEDAE;

EID: 57049175068     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00266.2008     Document Type: Article

References (56)

1. Ben-Yosef Y, Lahat N, Shapiro S, Bitterman H, Miller A. Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circ Res 90: 784-791, 2002.
2. Bose C, Bhuvaneswaran C, Udupa KB. Age-related alteration in hepatic acyl-CoA: cholesterol acyltransferase and its relation to LDL receptor and MAPK. Mech Ageing Dev 126: 740-751, 2005.
3. Chang TW, Weinstein L. Inactivation of Treponema pallidum by silver sulfadiazine. Antimicrob Agents Chemother 7: 538-539, 1975.
4. Chau YP, Shiah SG, Don MJ, Kuo ML. Involvement of hydrogen peroxide in topoisomerase inhibitor beta-lapachone-induced apoptosis and differentiation in human leukemia cells. Free Radic Biol Med 24: 660-670, 1998.
5. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495, 1996.
6. Davidson JM. Inflammation: Basic Principles and Clinical Correlates. New York: Raven, 1992.
7. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268: 14553-14556, 1993.
8. De Almeida ER, da Silva Filho AA, dos Santos ER, Lopes CA. Antiinflammatory action of lapachol. J Ethnopharmacol 29: 239-241, 1990.
9. Kip1) and Bak in the beta-lapachone-induced apoptosis of human prostate cancer cells. Mol Pharmacol 59: 784-794, 2001.
10. Edgell CJ, Haizlip JE, Bagnell CR, Packenham JP, Harrison P, Wilbourn B, Madden VJ. Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926. In Vitro Cell Dev Biol 26: 1167-1172, 1990.
11. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80: 3734-3737, 1983.
12. Frey MR, Dise RS, Edelblum KL, Polk DB. p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration. EMBO J 25: 5683-5692, 2006.
13. Frey MR, Golovin A, Polk DB. Epidermal growth factor-stimulated intestinal epithelial cell migration requires Src family kinase-dependent p38 MAPK signaling. J Biol Chem 279: 44513-44521, 2004.
14. Gabbiani G, Hirschel BJ, Ryan GB, Statkov PR, Majno G. Granulation tissue as a contractile organ. A study of structure and function. J Exp Med 135: 719-734, 1972.
15. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 136: 1235-1246, 1990.
16. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 124: 401-404, 1994.
17. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 87: 677-682, 2000.
18. Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 120: 577-585, 1993.
19. Katz MH, Alvarez AF, Kirsner RS, Eaglstein WH, Falanga V. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. J Am Acad Dermatol 25: 1054-1058, 1991.
20. Kim TJ, Yun YP. Potent inhibition of serum-stimulated responses in vascular smooth muscle cell proliferation by 2-chloro-3-(4-hexylphenyl)-amino- 1,4-naphthoquinone, a newly synthesized 1,4-naphthoquinone derivative. Biol Pharm Bull 30: 121-127, 2007.
21. Kumara Swamy HM, Krishna V, Shankarmurthy K, Abdul RB, Mankani KL, Mahadevan KM, Harish BG, Raja NH. Wound healing activity of embelin isolated from the ethanol extract of leaves of Embelia ribes Burm. J Ethnopharmacol 109: 529-534, 2007.
22. Lai CC, Liu TJ, Ho LK, Don MJ, Chau YP. beta-Lapachone induced cell death in human hepatoma (HepA2) cells. Histol Histopathol 13: 89-97, 1998.
23. Li CJ, Li YZ, Pinto AV, Pardee AB. Potent inhibition of tumor survival in vivo by beta-lapachone plus taxol: combining drugs imposes different artificial checkpoints. Proc Natl Acad Sci USA 96: 13369-13374, 1999.
24. Lin MT, Chang CC, Chen ST, Chang HL, Su JL, Chau YP, Kuo ML. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation. J Biol Chem 279: 24015-24023, 2004.
25. Liu B, Ryer EJ, Kundi R, Kamiya K, Itoh H, Faries PL, Sakakibara K, Kent KC. Protein kinase C-delta regulates migration and proliferation of vascular smooth muscle cells through the extracellular signal-regulated kinase 1/2. J Vasc Surg 45: 160-168, 2007.
26. Liu SH, Tzeng HP, Kuo ML, Lin-Shiau SY. Inhibition of inducible nitric oxide synthase by beta-lapachone in rat alveolar macrophages and aorta. Br J Pharmacol 126: 746-750, 1999.
27. Liu TJ, Lin SY, Chau YP. Inhibition of poly(ADP-ribose) polymerase activation attenuates beta-lapachone-induced necrotic cell death in human osteosarcoma cells. Toxicol Appl Pharmacol 182: 116-125, 2002.
28. Lowbury EJ, Babb JR, Bridges K, Jackson DM. Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant Gram-negative bacilli. Br Med J 1: 493-496, 1976.
29. Martin P. Wound healing - Aiming for perfect skin regeneration. Science 276: 75-81, 1997.
30. Mehrotra M, Krane SM, Walters K, Pilbeam C. Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells. J Cell Biochem 93: 741-752, 2004.
31. Moon DO, Choi YH, Kim ND, Park YM, Kim GY. Anti-inflammatory effects of beta-lapachone in lipopolysaccharide-stimulated BV2 microglia. Int Immunopharmacol 7: 506-514, 2007.
32. Muller L, Valdenaire O, Barret A, Korth P, Pinet F, Corvol P, Tougard C. Expression of the endothelin-converting enzyme-1 isoforms in endothelial cells. J Cardiovasc Pharmacol 36: S15-S18, 2000.
33. Munoz-Chapuli R, Quesada AR, Angel MM. Angiogenesis and signal transduction in endothelial cells. Cell Mol Life Sci 61: 2224-2243, 2004.
34. Ough M, Lewis A, Bey EA, Gao J, Ritchie JM, Bornmann W, Boothman DA, Oberley LW, Cullen JJ. Efficacy of beta-lapachone in pancreatic cancer treatment: exploiting the novel, therapeutic target NQO1. Cancer Biol Ther 4: 95-102, 2005.
35. Pereira CF, Boven LA, Middel J, Verhoef J, Nottet HS. Induction of cyclooxygenase-2 expression during HIV-1-infected monocyte-derived macrophage and human brain microvascular endothelial cell interactions. J Leukoc Biol 68: 423-428, 2000.
36. Pereira EM, Machado TB, Leal IC, Jesus DM, Damaso CR, Pinto AV, Giambiagi-deMarval M, Kuster RM, Santos KR. Tabebuia avellanedae naphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivo dermal irritability analysis. Ann Clin Microbiol Antimicrob 5: 5, 2006.
37. Pink JJ, Planchon SM, Tagliarino C, Varnes ME, Siegel D, Boothman DA. NAD(P)H:quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity. J Biol Chem 275: 5416-5424, 2000.
38. Rudolph R, Berg J, Ehrlich HP. Wound contraction and scar contracture. In: Wound Healing: Biochemical and Clinical Aspects, edited by Cohen IK, Diegelmann RF, and Lindblad WJ. Philadelphia, PA: Saunders, 1992, p. 114.
39. Saika S. TGF-beta signal transduction in corneal wound healing as a therapeutic target. Cornea 23: S25-S30, 2004.
40. Salameh A, Galvagni F, Bardelli M, Bussolino F, Oliviero S. Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways. Blood 106: 3423-3431, 2005.
41. Schaffner-Sabba K, Schmidt-Ruppin KH, Wehrli W, Schuerch AR, Wasley JW. beta-Lapachone: synthesis of derivatives and activities in tumor models. J Med Chem 27: 990-994, 1984.
42. Sharma GD, He J, Bazan HE. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J Biol Chem 278: 21989-21997, 2003.
43. 2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor beta-lapachone-induced apoptosis through an oxidation-dependent pathway. Cancer Res 59: 391-398, 1999.
44. Siegel D, Ross D. Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues. Free Radic Biol Med 29: 246-253, 2000.
45. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 341: 738-746, 1999.
46. Staton CA, Brown NJ, Lewis CE. The role of fibrinogen and related fragments in tumour angiogenesis and metastasis. Expert Opin Biol Ther 3: 1105-1120, 2003.
47. Stula M, Orzechowski HD, Gschwend S, Vetter R, von HR, Dietz R, Paul M. Influence of sustained mechanical stress on Egr-1 mRNA expression in cultured human endothelial cells. Mol Cell Biochem 210: 101-108, 2000.
48. Tagliarino C, Pink JJ, Reinicke KE, Simmers SM, Wuerzberger-Davis SM, Boothman DA. Mu-calpain activation in beta-lapachone-mediated apoptosis. Cancer Biol Ther 2: 141-152, 2003.
49. Tanaka K, Abe M, Sato Y. Roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the signal transduction of basic fibroblast growth factor in endothelial cells during angiogenesis. Jpn J Cancer Res 90: 647-654, 1999.
50. Tzeng HP, Ho FM, Chao KF, Kuo ML, Lin-Shiau SY, Liu SH. beta-Lapachone reduces endotoxin-induced macrophage activation and lung edema and mortality. Am J Respir Crit Care Med 168: 85-91, 2003.
51. Ueda S, Umemura T, Dohguchi K, Matsuzaki T, Tokuda H, Nishino H, Iwashima A. Production of anti-tumour-promoting furanonaphthoquinones in Tabebuia avellanedae cell cultures. Phytochemistry 36: 323-325, 1994.
52. Van Oost BA, Edgell CJ, Hay CW, MacGillivray RT. Isolation of a human von Willebrand factor cDNA from the hybrid endothelial cell line EA.hy926. Biochem Cell Biol 64: 699-705, 1986.
53. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 83: 835-870, 2003.
54. Wetzler C, Kampfer H, Stallmeyer B, Pfeilschifter J, Frank S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 115: 245-253, 2000.
55. Winstanley EW. The connective-tissue reaction in the healing of full-thickness excised skin wounds in the thoracic and metatarsal regions of the dog. J Comp Pathol 86: 211-219, 1976.
56. Zavan B, Brun P, Vindigni V, Amadori A, Habeler W, Pontisso P, Montemurro D, Abatangelo G, Cortivo R. Extracellular matrix-enriched polymeric scaffolds as a substrate for hepatocyte cultures: in vitro and in vivo studies. Biomaterials 26: 7038-7045, 2005.